RAM

Riggs Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$908	Hold	1,000	–	–	﹤0.01%	780
2025 Q1	$452	Hold	1,000	–	–	﹤0.01%	572
2024 Q4	$496	Hold	1,000	–	–	﹤0.01%	547
2024 Q3	$906	Sell	1,000 -8,600	-90%	-$7.79K	﹤0.01%	455
2024 Q2	$9.58K	Hold	9,600	–	–	﹤0.01%	253
2024 Q1	$14.2K	Hold	9,600	–	–	﹤0.01%	223
2023 Q4	$10.5K	Sell	9,600 -1,000	-9%	-$1.09K	﹤0.01%	243
2023 Q3	$12.5K	Hold	10,600	–	–	﹤0.01%	226
2023 Q2	$14.9K	Hold	10,600	–	–	0.01%	213
2023 Q1	$15.9K	Hold	10,600	–	–	0.01%	196
2022 Q4	$12.4K	Hold	10,600	–	–	0.01%	199
2022 Q3	$12K	Hold	10,600	–	–	﹤0.01%	206
2022 Q2	$17K	Hold	10,600	–	–	0.01%	184
2022 Q1	$16K	Hold	10,600	–	–	﹤0.01%	210
2021 Q4	$26K	Hold	10,600	–	–	0.01%	194
2021 Q3	$27K	Hold	10,600	–	–	0.01%	179
2021 Q2	$30K	Hold	10,600	–	–	0.01%	177
2021 Q1	$25K	Hold	10,600	–	–	0.01%	178
2020 Q4	$19K	Buy	+10,600	New	+$19K	0.01%	178
2020 Q3	–	Sell	-11,600	Closed	-$10K	–	207
2020 Q2	$10K	Hold	11,600	–	–	﹤0.01%	172
2020 Q1	$9K	Hold	11,600	–	–	0.01%	172
2019 Q4	$10K	Hold	11,600	–	–	﹤0.01%	205
2019 Q3	$11K	Hold	11,600	–	–	0.01%	176
2019 Q2	$13K	Hold	11,600	–	–	0.01%	173
2019 Q1	$15K	Hold	11,600	–	–	0.01%	161
2018 Q4	$11K	Sell	11,600 -1,500	-11%	-$1.42K	0.01%	155
2018 Q3	$30K	Hold	13,100	–	–	0.01%	131
2018 Q2	$27K	Sell	13,100 -400	-3%	-$824	0.01%	140
2018 Q1	$36K	Buy	13,500 +400	+3%	+$1.07K	0.01%	136
2017 Q4	$28K	Hold	13,100	–	–	0.01%	150
2017 Q3	$37K	Hold	13,100	–	–	0.02%	137
2017 Q2	$41K	Buy	13,100 +4,000	+44%	+$12.5K	0.02%	144
2017 Q1	$31K	Buy	9,100 +1,000	+12%	+$3.41K	0.02%	142
2016 Q4	$29K	Hold	8,100	–	–	0.01%	140
2016 Q3	$32K	Buy	+8,100	New	+$32K	0.02%	135